Hetero Labs Limited Unit V
Hetero Labs Limited Unit V appears in FDA public data with 9 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1213-2018, Class II) was initiated on August 20, 2018.
Summary
- Total Recalls
- 9 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Known Names
hetero labs limited (unit v), hetero labs limited unit v
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1213-2018 | Class II | Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Uni | August 20, 2018 |
| D-0081-2019 | Class I | Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V, | August 15, 2018 |
| D-1115-2018 | Class II | Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 160 mg, 90 tablets Rx Only Manufactured for: | August 8, 2018 |
| D-1113-2018 | Class II | Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 40 mg, 30 Tablets Rx Only Manufactured for: C | August 8, 2018 |
| D-1114-2018 | Class II | Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 80 mg, 90 count bottles, Rx Only Manufactured | August 8, 2018 |
| D-1116-2018 | Class II | Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 320 mg, 90 tablets, Rx Only Manufactured for: | August 8, 2018 |
| D-0602-2018 | Class II | Valacyclovir Tablets USP 1 gram, 30-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, | February 13, 2018 |
| D-0601-2018 | Class II | Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuti | February 13, 2018 |
| D-0415-2018 | Class II | Famciclovir Tablets, 500 mg, 30-count bottles, Rx Only, Manufactured For: Camber Pharmaceuticals. In | December 22, 2017 |